Skip to main content
. Author manuscript; available in PMC: 2017 Aug 7.
Published in final edited form as: Mol Imaging. 2014;13:10.2310/7290.2014.00031. doi: 10.2310/7290.2014.00031

Figure. 1.

Figure. 1

Reduced uptake of [18F]fallypride is qualitatively detectable in the Tg rat compared to the control rat. Shown are axial, sagittal, and coronal MR co-registered, normalized [18F]fallypride PET images at the level of the striatum from (A), a representative adult HIV-1 Tg rat and (B), a representative age-matched control. Both images represent summed data from PET acquired between 50 to 90 min after injection and are displayed on a common scale (0–20 SUV, radioactivity normalized by injected dose). Time-activity curves of [18F]fallypride injections obtained from the dorsal striatum (DS) and ventral striatum (VS) (left and right averaged), thalamus (Th), and cerebellum are shown in (C) an adult HIV-1 Tg and (D) an adult control rat. The solid lines represent the quality of data fit obtained using the 2-Tissue reference model with the cerebellum as reference.